Skip to content

BE1 Study Spain - CAPSULE SYSTEM FOR COLOSTOMATES

BE1 Study Spain - CAPSULE SYSTEM FOR COLOSTOMATES

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04239183
Acronym
BE1
Enrollment
240
Registered
2020-01-23
Start date
2020-01-31
Completion date
2021-01-31
Last updated
2020-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life of Colostomized Patient

Keywords

stomy, stomatherapy, colestomy

Brief summary

A comparative study on the improvement of quality of life of colostomized patients using the new Be1 device with capsule system.

Detailed description

The primary objective is to demonstrate improvement of quality of life (difference of at least 5 points in the StomaQoL questionnaire) among descending colostomy patients, establishing the following comparisons: 1. Patients with recent surgery who after one month using a current two-piece mechanical device switch to the new Be1 device with capsule system versus patients who after one month continue to use the same current two-piece mechanical device during four months. 2. Patients who have been using a current two-piece mechanical device during more than 6 months after an ostomy and agree to switch to the new Be1 device with capsule system during four months. The following secondary objectives have been defined: * Assessment of patient satisfaction with the new Be1 device with capsule system versus a current two-piece mechanical device. * Demonstration that the new Be1 device with capsule system improves the microbiota of the colostomized patient.

Interventions

DEVICEStomatherapy

Demonstrate improvement of quality of life (difference of at least 5 points in the StomaQoL questionnaire (21)) among descending colostomy patients, establishing the following comparisons.

Sponsors

B. Braun Medical SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Inclusion criteria groups 1 and 2 * Patients of at least 18 years of age. * Recently operated patients with a descending colostomy. * Patients with a non-retracted stoma measuring no more than 1.5 cm in height. * Patients agreeing to participate in the study and who have signed the informed consent in accordance with the legal requirements. * Patients who in the opinion of the stoma therapist are candidates for a two-piece mechanical device. Inclusion criteria group 3 * Patients of at least 18 years of age. * Patients with a descending colostomy for over 6 months and who carry a two-piece mechanical device. * Patients with a non-retracted stoma measuring no more than 1.5 cm in height. * Patients agreeing to participate in the study and who have signed the informed consent in accordance with the legal requirements * Patients who in the opinion of the stoma therapist are candidates for use of the Be1 device with capsule system.

Design outcomes

Primary

MeasureTime frameDescription
StomaQoL1 monthto demonstrate improvement of quality of life (difference of at least 5 points in the StomaQoL questionnaire) among descending colostomy patients

Secondary

MeasureTime frameDescription
Questionnaire1 monthAssessment of patient satisfaction with the new Be1 device with capsule system versus a current two-piece mechanical device.
Biota Analysis1 monthDemonstration that the new Be1 device with capsule system improves the microbiota of the colostomized patient

Contacts

Primary ContactMM

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026